Former UFC Star Ben Askren Being Prepared for Lung Transplant, Says Wife
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Former Bellator and UFC star Ben Askren continues to fight for his life in the hospital. There were rumors that he died, which were immediately shot down by his wife, Amy Askren.
Read more: Former UFC Star is 'Fighting for Life' As Wife Shoots Down Death Rumors
Amy has updated fans as much as possible via her personal Facebook page. Initially, she stated that Ben was dealing with severe pneumonia and that he was still hospitalized.
Now, she has revealed a far more harrowing update, as Ben is currently on sedation and is being prepped to receive a lung transplant.
LAS VEGAS, NEVADA - MARCH 02: Robbie Lawler (R) and Ben Askren trade punches during their welterweight bout during UFC 235 at T-Mobile Arena on March 02, 2019 in Las Vegas, Nevada.
LAS VEGAS, NEVADA - MARCH 02: Robbie Lawler (R) and Ben Askren trade punches during their welterweight bout during UFC 235 at T-Mobile Arena on March 02, 2019 in Las Vegas, Nevada."I haven't shared an update because Ben has been in limbo for a while and I was hoping to have him wake up and be the one to decide what to share. I've had some media people contact me that they are going to share an update and I would rather it come from me.
Her post on Facebook reads:
"Ben is still on a ventilator and ecmo to support him while he heals. There are good days and bad, but on the good, they have been able to wean his sedation enough for him to open his eyes and squeeze hands. His body can't handle coming off sedation too much yet. I'm still praying for a miracle with his current lungs, but they are currently starting the evaluation process for lung transplant.
"Please pray for his continued healing, and if transplant is the solution, that he can get on the list quickly and easily. I know transplants are such a blessing and I'm overwhelmed at the thought of him receiving a gift like that. No one would take better care of that gift than Ben.
"Thank you for every message and all of the support. Despite this awful situation, I'm feeling so blessed by the community we're surrounded by. Give your loved ones a hug today and make sure you're prepared situations like this. Ben is the healthiest guy I know and I never could have expected this."
Though the update offers some hope in the form of Ben being weaned off sedation, the aspect of his potentially needing a lung transplant is very worrisome.
The hope is Ben can recover fully, or is able to find a transplant should his lungs stop working due to whatever medical issue he is going through.
The entire MMA community has been shouting out Ben, including his podcast co-host and former UFC champion Daniel Cormier. Cormier co-hosts the "Funky and the Champ" podcast with Ben.
For more on the UFC, head to Newsweek Sports.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
7 hours ago
- Newsweek
New Vaccine Shows Promise Against One of the Deadliest Cancers
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Early clinical and preclinical results are showing that experimental mRNA and nanoparticle vaccines produced measurable immune responses against pancreatic cancer, one of the deadliest cancers, and that in small patient groups those immune responses correlated with delayed recurrence or prolonged survival. Why It Matters Pancreatic cancer has among the lowest survival rates of common cancers and limited effective treatments. Multiple small trials and preclinical studies published and reported in the past year indicated that novel vaccine platforms, including personalized mRNA vaccines and layered lipid nanoparticles, were able to induce tumor‑targeting T cells in patients and animal models, prompting researchers to plan larger trials. Pancreatic ductal adenocarcinoma had an approximate five‑year survival near 13 percent in recent reports, making it one of the most lethal common cancers. What To Know Researchers at Memorial Sloan Kettering (MSK) and collaborators ran a phase 1 trial in February testing a personalized mRNA vaccine called autogene cevumeran (BNT122, RO7198457) in 16 patients with operable pancreatic cancer who received surgery, chemotherapy and the vaccine, according to the peer reviewed journal Nature Medicine. Newsweek reached out to MSK via email for comment. The vaccine was developed and researched through a collaboration between BioNTech, an immunotherapy company, and Genentech, a member of the Roche Group. It is not a cure for the type of cancer itself; however, signs point to improving longevity in individuals who contract the disease. Investigators reported that half of participants mounted vaccine‑induced tumor‑specific T‑cell responses. Also, long-term efficacy was reported as patients with a vaccine-induced immune response had a reduced risk of cancer returning at three-year follow-up appointments compared with patients whose immune systems did not respond. Trials have occurred as cancer is on the rise this year compared to last, according to the American Cancer Society's 2025 annual Facts & Figures report. More than 2 million new cancer cases are expected this year, according to a 48-page report. Roughly 618,000 Americans are expected to die from cancer in 2025, equating to about 1,700 deaths per day, and both one-in-three men and women are said to develop cancer in their lifetime. These five cancers are predicted to take nearly 323,900 male lives in a year: Lung and bronchus—64,190 male deaths Prostate—35,770 male deaths Colon and rectum—28,900 male deaths Pancreas—27,050 male deaths Liver and intrahepatic bile duct—19,250 male deaths These five cancers are estimated to take nearly 294,220 female lives in a year, described by researchers as a "substantial" increase compared to 2024 numbers: Lung and bronchus—60,540 female deaths Breast—42,170 female deaths Pancreas—24,930 female deaths Colon and rectum—24,000 female deaths Uterine—13,860 female deaths Researchers reported early clinical and preclinical results showing that experimental mRNA and nanoparticle vaccines produced measurable immune responses against pancreatic cancer. Researchers reported early clinical and preclinical results showing that experimental mRNA and nanoparticle vaccines produced measurable immune responses against pancreatic cancer. Getty Images What People Are Saying Vinod Balachandran, a surgical oncologist at MSK and principal investigator of the February 2025 trial, said at the time of the trial's conclusion: "The latest data from the phase 1 trial are encouraging. They suggest this investigational therapeutic mRNA vaccine can mobilize anti-tumor T cells that may recognize pancreatic cancers as foreign, potentially years after vaccination." He added: "For patients with pancreatic cancer, our latest results continue to support the approach of using personalized mRNA vaccines to target neoantigens in each patient's tumor. If you can do this in pancreas cancer, theoretically you may be able to develop therapeutic vaccines for other cancer types." Immunologist Li Lily Wang, an associate professor of molecular medicine at the Case Western Reserve School of Medicine, said earlier this year: "This platform has the potential to transform clinical care for this devastating disease. I am excited to see that our novel nano-vaccine worked so well in eliciting vigorous responses from tumor-reactive T cells-which are typically low in numbers and unable to control tumor growth." What Happens Next? Researchers planned larger trials to test whether the vaccine‑induced immune responses translated into longer survival and lower recurrence rates. MSKCC and industry partners launched a phase 2 trial to evaluate the personalized pancreatic mRNA vaccine in a larger cohort following the encouraging phase 1 immune data. Across studies, authors and outside experts urged caution because the human data remained small. Investigators and commentators said larger randomized trials were necessary to determine whether the immune responses would translate into durable survival benefits and acceptable safety in broader patient populations.
Newsweek
7 hours ago
- Newsweek
Weight Loss May Improve Pregnancy Odds
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Weight loss interventions for people who are overweight and obese undertaken before turning to IVF could increase the chances of getting pregnant naturally. This is the conclusion of researchers from University of Oxford who reviewed 12 past studies involving nearly 2,000 patients from 1980 to May of this year. They compared a woman's weight to how likely they were to become pregnant either without IVF (unassisted pregnancy), with IVF (treatment-induced pregnancy) and overall (unassisted plus treatment-induced)—as well as whether they delivered a live baby. "All participants in the included studies were candidates for IVF. Before having IVF, they were offered weight loss support. The women who got pregnant naturally, ended up not needing to have IVF," study author and dietician Moscho Michalopoulou told Newsweek. Side view pregnant woman with advanced pregnant belly belly in hands. Side view pregnant woman with advanced pregnant belly belly in criteria included studies conducted on women who were at least 18 years old with a BMI of 27 kg/m² or greater who were seeking IVF with or without intracytoplasmic sperm injection treatment (ICSI) for infertility. "IVF and ICSI are assisted reproductive techniques where oocytes [cells involved in reproduction] are fertilized outside the body, before embryos are transferred back into the woman's womb. The key difference is how the fertilization is achieved," Michalopoulou explained. "Regular IVF egg and sperm are typically mixed in a Petri dish, with ICSI, the sperm is directly injected into the egg." The researchers found that participants were typically women in their early 30s with a median baseline BMI of 33.6 kg/m². The weight loss interventions studied included low-energy diets, an exercise program accompanied by healthy eating advice and pharmacotherapy accompanied by diet and physical activity advice. "Low-energy diets, also known as total diet replacements, typically use liquid formula products to replace real food and induce a much larger energy deficit with total energy intake of no more than 1000 kcal/day, followed by gradual reintroduction of foods for weight stabilization," Michalopoulou explained. She said these are safe for women when supervised and supported to follow such a program, with a lot of literature on the effectiveness of these diets. "In this one study, the main intervention being tested was high-intensity interval training (referenced as Kiel 2018 in the paper). At the same time, participants were advised to eat healthy as per national healthy eating recommendations," said Michalopoulou. In terms of the 'pharmacotherapy' intervention, she added, "Participants were instructed to take weight loss medication which was the main intervention being tested, but at the same time, they were given healthy eating advice or a hypocaloric diet [low in calories], plus advice on how to increase their physical activity, e.g. doing more steps, or doing exercise." Overall, weight loss interventions before IVF were associated with greater unassisted pregnancy rates, according to the researchers. "Regardless of weight loss method used, across all studies, women with obesity who participated in a supported weight loss program before IVF had 47 percent higher chances of getting pregnant naturally, compared to women in the comparator groups who typically received standard care," said Michalopoulou. "Therefore, more women in the intervention than in the comparator groups did not need to have IVF treatment to get pregnant, as they got pregnant naturally." However, evidence was inconclusive on the effect of weight loss interventions on treatment-induced pregnancies. Illustration representing IVF process with eggs fertilized with sperm. Illustration representing IVF process with eggs fertilized with sperm."It is unclear if weight loss interventions before IVF have an effect on the chances of getting pregnant through IVF. In some studies there were more IVF pregnancies in the intervention groups compared to standard care, in some others there were fewer IVF pregnancies compared to standard care—and in some others there was no difference in IVF pregnancy rates compared to standard care," Michalopoulou explained. "This large variability, combined with other methodological issues of the included studies, prevent us from having a clear conclusion on whether weight loss programs before IVF have an effect on IVF-induced pregnancy success or not." Evidence on the association between weight loss interventions before IVF and live births was uncertain—mainly because there were fewer studies that reported live birth outcomes—although there was moderate certainty of no association with pregnancy loss. "Obesity can lead to female infertility through hormone imbalance, insulin resistance, inflammation, and polycystic ovary syndrome. All of these can lead to ovulatory dysfunction," said Michalopoulou. "Obesity has also been associated with lower IVF success for women with infertility, such as requiring higher doses of treatment, reduced response to the medications, reduced chances of getting pregnant, and increased chances of miscarriage if a pregnancy is achieved." "Maintaining a healthier weight can help improve hormone balance, increase insulin sensitivity, reduce inflammation, and improve ovulation. For women seeking IVF, lowering their BMI to healthier levels may improve sensitivity and response to the treatment, improve egg quality and uterine function, and as a result, increase their chances of getting pregnant." However, everyone is different, the researcher noted. "Many larger women will have healthy pregnancies. But evidence shows that starting pregnancy carrying too much weight and gaining too much weight during pregnancy are both associated with greater risks of complications. This does not mean that every woman living with obesity will develop these complications—just that there will likely be more complications than in women who start pregnancy in the normal BMI range" The researchers hope their systematic review and analysis of randomized controlled trials will lead to more advanced trials. "We already know weight loss can help with fertility, but whether it improves IVF outcomes is far less certain. This review sheds some light, but most of the studies are small and at high risk of bias, so the results need cautious interpretation. IVF bypasses many obesity-related barriers, but what is still unclear is if delaying treatment for weight loss truly boosts success rates," said Ying Cheong—a professor of reproductive medicine of the University of Southampton who was not involved in the present study—in a statement. "Weight loss interventions before IVF appear to increase the chances of pregnancy, especially through natural conception, which may negate the need for IVF treatment, and does not seem to increase the risk of pregnancy loss. This offers hope to women with obesity and infertility," Michalopoulou said. "However, the evidence is limited and unclear on whether weight loss interventions before IVF have an effect on live birth rates, and more evidence from larger, high-quality trials is needed to test this." Do you have a tip on a health story that Newsweek should be covering? Do you have a question about pregnancy? Let us know via health@ Reference Michalopoulou, M., Jebb, S. A., Hobson, A., Khaw, S. C., Stevens, R., Melo, P., Haffner, S. J. P., Clay, K. S., Mounsey, S., Granne, I., Lim, L., Child, T., & Astbury, N. M. (2025). The effect of weight loss before in vitro fertilization on reproductive outcomes in women with obesity: A systematic review and meta-analysis. Annals of Internal Medicine, 178(9).
Newsweek
7 hours ago
- Newsweek
Social Security Announces Major Change
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The Social Security Administration announced that it has added 13 conditions to its Compassionate Allowances (CAL) list on Monday. The added conditions aim to accelerate disability determinations for people with serious medical conditions, the agency said in a press release. Why It Matters The CAL initiative was designed to fast-track claims for applicants whose diagnoses clearly met Social Security's statutory standard for disability. More than 1.1 million applicants have been approved through the accelerated pathway since CAL began, according to the SSA press release. What To Know The expansion increased the total number of conditions on the CAL list to 300, which the SSA said would help the agency reach decisions more quickly for applicants with specific, severe diseases and conditions. The 13 conditions added in the Monday announcement include: Au-Kline Syndrome Bilateral Anophthalmia Carey-Fineman-Ziter Syndrome Harlequin Ichthyosis – Child Hematopoietic Stem Cell Transplantation LMNA-related Congenital Muscular Dystrophy Progressive Muscular Atrophy Pulmonary Amyloidosis – AL Type Rasmussen Encephalitis Thymic Carcinoma Turnpenny-Fry Syndrome WHO Grade III Meningiomas Zhu-Tokita-Takenouchi-Kim Syndrome According to the SSA, when applicants submit medical evidence indicating a CAL condition, the agency can identify and prioritize those claims using advanced tools. The CAL list was first introduced to reduce waiting times for applicants with clearly disabling conditions, and the SSA said the program remains fully policy-compliant while speeding determinations for eligible claimants. File photo of a Social Security Administration office in Washington, D.C. File photo of a Social Security Administration office in Washington, D.C. SAUL LOEB/AFP via Getty Images What People Are Saying SSA Commissioner Frank Bisignano, in a statement: "We are constantly looking for ways to improve our disability programs and serve the public more effectively. By adding these 13 conditions to the Compassionate Allowances list, we are helping more people with devastating diagnoses to quickly receive the support they need. This is part of our broader commitment to making the disability determination process as responsive and compassionate as possible." Alex Beene, a financial literacy instructor for the University of Tennessee at Martin, told Newsweek: "This is certainly welcome news for Americans who have any of the 13 added conditions to the list of those that now qualify for expedited consideration under the Compassionate Allowances List the administration provides. For some disability benefits under SSA, wait times can be lengthy in order for the administration to verify the potential beneficiary's condition and determine the next steps." Kevin Thompson, the CEO of 9i Capital Group and the host of the 9innings podcast, told Newsweek: "While claims still have to go through the traditional process, the agency is now using advanced technology to speed things up. If you're diagnosed with something on the Compassionate Allowances list, your claim could be processed much faster." What Happens Next The SSA encourages applicants to apply online at if they believe they have a CAL condition. "Long term, this could mean fewer delays and less financial strain for those facing serious medical conditions, but it also puts pressure on Social Security to keep up with technology and ensure the system remains fair and accurate," Thompson said.
